Skip to main content

Immunogenetics of Graves’ Disease

  • Chapter
Immunology of Endocrine Diseases

Part of the book series: Immunology and Medicine ((IMME,volume 3))

Abstract

The actual aetiology of Graves’ disease, like that of Hashimoto’s chronic thyroiditis, remains unknown. The condition of hyperthyroidism was initially recognized by Parry in 1786 and recorded cases were published in 18251. Subsequently, Graves, from whom the eponym has been derived, described three cases in greater detail in 18352. Basedow also described the condition in great detail in 18403. It is recognized that females are affected by Graves’ disease much more commonly than males, as is true for virtually all thyroidal disorders, the reported ratios varying from 4:1 to 10:1. The familial occurrence of hyperthyroidism has been recognized by several investigators for many years. Bartels found evidence of a familial disposition in 60% of cases with Graves’ disease4. Pedigrees have been published that have shown a high incidence of Graves’ disease in families; however, a definitive pattern of inheritance has not been established. Although hereditary factors appear to be involved in the pathogenesis of Graves’ disease, it is apparent that a combination of several genetic and environmental determinants are involved rather than a single gene as being a predominant factor. The twin and clinical family studies initially demonstrated the important role of hereditary factors in Graves’ disease. The investigation of autoantibodies and immunogenetic markers have further supported the hereditary importance. Furthermore, the greater rate of concordance of hyperthyroidism among monozygotic twins is also indicative of hereditary determinants in this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parry, C. H. (1825). Collections from Unpublished Medical Writings of the Late Caleb Hillier Parry. Vol. 2, p. 111. (London: Underwoods).

    Google Scholar 

  2. Graves, R. G. (1835). Newly observed affection of the thyroid gland in females. Lond. Med. Surg. J., 7, 516–20.

    Google Scholar 

  3. von Basedow, K. A. (1840). Exophthalmos druch Hypertrophie der Zellgewebes in der Augenhöhle. Wschr. Ges. Heilk14, 197.

    Google Scholar 

  4. Bartels, E. D. (1941). Heredity in Graves’Disease. (Copenhagen: Munksgaard).

    Google Scholar 

  5. Verscheur, O. V. (1958). Die Zwillingsforschung im Dienste der innern Medizin. Verband. Deut. Gesell Inn. Med., 64, 262–73.

    Google Scholar 

  6. Tamai, H., Suematsu, H., Ikemi, Y., Kuma, K., Matsuzuka, F., Kumagai, L. F., Shizume, K. and Nagataki, S. (1978). Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves’ disease. J. Clin. Endocrinol. Met ab., 47,475–9.

    Article  CAS  Google Scholar 

  7. Tamai, H., Ohsako, N., Takeno, K., Fukino, O., Takahashi, H., Kuma, K., Kumagai, L. F. and Nagataki, S. (1980). Changes in thyroid function in euthyroid subjects with family history of Graves’disease; a follow-up study of 69 patients. J. Clin. Endocrinol. Metab., 51, 1123–8.

    Article  PubMed  CAS  Google Scholar 

  8. Chopra, I. J., Solomon, D. H., Chopra, U., Yoshihara, E., Teraski, P. L. and Smith, F. (1977). Abnormalities in thyroid function in relatives of patients with Graves’ disease and Hashimoto’s thyroiditis: lack of correlation with inheritance of HLA-B8. J. Clin. Endocrinol. Metab., 45, 45–54.

    Article  PubMed  CAS  Google Scholar 

  9. Ingbar, S. H., Freinkel, N., Dowling, J. T. and Kumagai, L. F. (1965). Abnormalities of iodine metabolism in euthyroid relatives with Graves’ disease, J. Clin. Invest., 35, 714.

    Google Scholar 

  10. Tanaka, T., Katayama, S., Kuma, K., Tamai, T., Matsuzuka, F. and Hidaka, H. (1980). Clinical and pathological significance of sibling Graves’ disease. Acta Endocrinol., 94, 498–502.

    PubMed  CAS  Google Scholar 

  11. Tamai, H., Nakagawa, T., Ohsako, N., Fukino, O., Takahashi, H., Matsuzuka, F., Kuma, K. and Nagataki, S. (1980). Changes in thyroid functions in patients with euthyroid Graves’ disease. J. Clin. Endocrinol. Metab., 50, 108–12.

    Article  PubMed  CAS  Google Scholar 

  12. Banovac, K., Zakarija, M., Mckenzie, J. M., Witte, S. and Sekso, M. (1981). Absence of thyroid stimulating antibody and long acting thyroid stimulator in relatives of Graves’ disease patients. J. Clin. Endocrinol. Metab., 53, 651–3.

    Article  PubMed  CAS  Google Scholar 

  13. Werner, S. C. (1978). Etiology, pathogenesis, immune system, other mechanism, emotional factors. In Werner, S. C. and Ingbar, S. H. (eds.) The Thyroid: A Fundamental and Clinical Text. 4th Edn., p. 616. (New York: Harper and Row).

    Google Scholar 

  14. Kriss, J. P., Pleshakov, V. and Chien, J. R. (1964). Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibrial myxedema. J. Clin. Endocrinol. Metab., 24, 1005–11.

    Article  PubMed  CAS  Google Scholar 

  15. Bonnyns, M., Vanhaelst, J., Golstein, J., Caunchie, C., Ermans, A. M. and Bastenie, P. A (1973). Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves’disease. Clin. Endocrinol., 2, 211-211 SI.

    Article  Google Scholar 

  16. Kitchin, F. D. and Weinstein, I. B. (1978). Genetic factors in thyroid disease. In Werner, S. C. and Ingbar, S. H. (eds.) The Thyroid: A Fundamental and Clinical Text. 4th Edn., p. 495. (New York: Harper and Row).

    Google Scholar 

  17. Howel-Evans, A. W., Woodrow, J. C. and McDougall, C. D. M. (1967). Antibody in families of thyrotoxic patients. Lancet, 1, 636–41.

    Article  Google Scholar 

  18. Friedman, J. M. and Fialkow, P. J. (1978). The genetics of Graves’ disease. Clin. Endocrinol. Metab., 1, 47–65.

    Article  Google Scholar 

  19. Fialkow, P. J., Thuline, H. C., Hecht, F. and Bryant, J. (1971). Familial predisposition to thyroid disease in Down’s syndrome: controlled immunoclinical studies. Am. J. Hum. Gen., 23, 67–86.

    CAS  Google Scholar 

  20. Azizi, F., Chandler, H., Bozorgzadeh, H. and Braverman, L. E. (1974). The occurrence of hyperthyroidism in patients with Down’s syndrome. Hosp. Med. J., 134, 303–6.

    CAS  Google Scholar 

  21. Fialkow, P. J. (1970). Thyroid autoimmunity and Down’s syndrome. Ann. N. Y. Acad. Sei., 171,500–11.

    Article  Google Scholar 

  22. Boas, N. F. and Oher, W. B. (1946). Hereditary exophthalmic goitre: report of eleven children in one family. J. Clin. Endocrinol. Metab., 6, 575–82.

    Article  PubMed  CAS  Google Scholar 

  23. Volpe, R., Farid, N. R., Von Westarp, C. and Row, V. V. (1974). The pathogenesis of Graves’disease and Hashimoto’s thyroiditis. Clin. Endocrinol., 3, 239–61.

    Article  CAS  Google Scholar 

  24. Volpe, R. (1981). Auto-immunity in thyroid disease. In Volpe, R. (ed.) Monographs on Endocrinology, Auto-immunity in the Endocrine System, p. 108. (New York: Springer-Verlag).

    Google Scholar 

  25. Strakosh, R. D., Wenzel, B. E., Row, V. V. and Volpe, R. (1982). Immunology of autoimmune thyroid disease. N. Engl. J. Med., 307, 1499–507.

    Article  Google Scholar 

  26. McGregor, A. M., Peterson, M. M., Capifferi, R., Evered, D. C., Rees-Smith, B. and Hall, R. (1979). Effects of radioiodine on thyrotropin binding inhibiting immunoglobulin in Graves’disease. Clin. Endocrinol., 11,437–44.

    Article  CAS  Google Scholar 

  27. Schleusener, H., Kotulla, P., Finke, R., Sorje, H., Meinhold, H., Adlkofer, F. and Wenzel, K. W. (1978). Relationship between thyroid status and Graves’ disease - specific immunoglobulin. J. Clin. Endocrinol. Me tab., 41, 379–84.

    Article  Google Scholar 

  28. Endo, K., Kasagi, K., Konishi, J., Ikekubo, K., Okuno, T., Takeda, Y., Mori, T. and Torizuka, K. (1978). Detection and properties of TSH binding inhibitor immunoglobulin in patients with Graves’disease and Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 46, 734–9.

    Article  PubMed  CAS  Google Scholar 

  29. Teng, C. S., Yeung, R. T. T., Khoo, R. K. K. and Alagaratnam, T. T. (1980). A prospective study of the changes in thyrotropin binding inhibitory immunoglobulin in Graves’ disease treated by subtotal thyroidectomy or radioactive iodine. J. Clin. Endocrinol. Metab., 50, 1005–10.

    Article  PubMed  CAS  Google Scholar 

  30. Kishihara, M., Nakao, Y., Baba, Y., Kobayashi, N., Matukura, S., Kuma, K. and Fujita, T. (1981). Interaction between thyrotropin (TSH) binding inhibitor immunoglobulin (TBII) and soluble TSH receptors in fat cell. J. Clin. Endocrinol. Metab., 52, 665–70.

    Article  PubMed  CAS  Google Scholar 

  31. Burman, K. D. and Baker, J. R. (1985). Immune mechanisms in Graves’disease. Endocrine Rev., 6, 183–232.

    Article  CAS  Google Scholar 

  32. Mukhtar, E. D., Smith, B. R., Pyle, G. A., Hall, R. and Vice, P. (1975). Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drug. Lancet, 1, 713–5.

    Article  PubMed  CAS  Google Scholar 

  33. McGregor, A. M., McLachlan, S. M., Rees-Smith, B. and Hall, R. (1979). Effect of irradiation on thyroid-autoantibody production. Lancet, 2, 442–4.

    Article  PubMed  CAS  Google Scholar 

  34. Zakarija, M., McKenzie, J. M. and Banovac, K. (1980). Clinical significance of assay of thyroid stimulating antibody in Graves’ disease. Ann. Int. Med., 93, 28–32.

    PubMed  CAS  Google Scholar 

  35. Beck, K., Feldt-Rasmussen, U., Bliddal, H., Date, J. and Blickert-Toft, M. (1982). The acute changes in thyroid stimulating immunoglobulin, thyroglobulin and thyroglobulin antibodies following subtotal thyroidectomy. Clin. Endocrinol., 16, 235–42.

    Article  Google Scholar 

  36. Macchia, E., Fenzi, G. F., Monzani, F., Lippi, F., Vitti, P., Grasso, L., Bartalena, L., Baschieri, L. and Pinchera, A. (1981). Comparison between thyroid stimulating and TSH binding inhibiting immunoglobulins of Graves’disease. Clin. Endocrinol., 15, 175–82.

    Article  CAS  Google Scholar 

  37. Kuzuya, N., Chiu, S. C., Ikeda, H., Uchimura, H., Ito, K. and Nagataki, S. (1979). Correlation between thyroid stimulators and 3,5,3’-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drug: comparison of assays by thyroid stimulating and thyrotropin displacing activities. J. Clin. Endocrinol. Metab., 48, 706–11.

    Article  PubMed  CAS  Google Scholar 

  38. Karlsson, F. A. and Dahlberg, P. A. (1981). Thyroid stimulating antibody (TSAb) in patients with Graves’ disease undergoing antithyroid drug treatment: indicators of activity of disease. Clin. Endocrinol., 14, 579–85.

    Article  CAS  Google Scholar 

  39. Etienne-Decerf, J. and Winand, R. J. (1981). A sensitive technique for determination of thyroid-stimulating immunoglobulin in unfractionated serum. Clin. Endocrinol., 14, 83–91.

    Article  CAS  Google Scholar 

  40. Rapoport, B., Greenspan, F. S., Filettr, S. and Pepitone, M. (1984). Clinical experience with a human thyroid cell bioassay for thyroid stimulating immunoglobulin. J. Clin. Endocrinol. Metab., 58, 332–8.

    Article  PubMed  CAS  Google Scholar 

  41. Atkinson, S. and Kendall-Taylor, P. (1981). The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies. J. Clin. Endocrin. Metab., 53, 1263–6.

    Article  CAS  Google Scholar 

  42. Smyth, P. P. A., Neylan, D. and O’Donovan, D. K. (1982). The prevalence of thyroid stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J. Clin. Endocrinol. Metab., 54, 357–61.

    Article  PubMed  CAS  Google Scholar 

  43. Davis, T. F., Yeo, P. P. B., Evered, D. C., Clark, F., Smith, B. R. and Hall, R. (1977 Value of thyroid stimulating antibody determination in predicting short-term thyrotoxic relapse in Graves’disease. Lancet, 1, 1181–2.

    Article  Google Scholar 

  44. Matsuura, N., Yamada, T., Nohara, Y., Knoishi, J., Kasagi, K., Endo, K., Kojima, H. and Wataya, K. (1980). Familial neonatal transient hypothyroidism due to maternal TSH- binding inhibition immunoglobulin. N. Engl. J. Med., 303, 738–41.

    Article  PubMed  CAS  Google Scholar 

  45. Takasu, N., Mori, T., Koizumi, Y., Takeuchi, S. and Yamada, T. (1984). Transient neonatal hypothyroidism due to maternal immunoglobulin that inhibit thyrotropin-binding and post-receptor processes./Clin. Endocrinol. Metab., 59, 142–146.

    Article  CAS  Google Scholar 

  46. Takasu, N., Naka, M., Mori, T. and Yamada, T. (1984). Two types of thyroid function- blocking antibodies in autoimmune atrophic thyroiditis and transient neonatal hypothyroidism due to maternal IgG. Clin. Endocrinol., 21, 345–55.

    Article  CAS  Google Scholar 

  47. Konishi, J., Iida, Y., Endo, K., Misaki, T., Nohara, Y., Matsuura, N., Mori, T. and Torizuka, K. (1983). Inhibition of thyrotropin-induced adenosin 3’5’-monophosphate increase by immunoglobulins from patients with primary myxedema. J. Clin. Endocrinol. Metab., 57, 544–9.

    Article  PubMed  CAS  Google Scholar 

  48. Steel, N. R., Weightman, D. R., Taylor, J. J. and Kendall-Taylor, P. (1984). Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism. Br. Med. J., 288, 1559–64.

    Article  CAS  Google Scholar 

  49. Frelinger, J. A. and Shreffler, D. C. (1975). The major histocompatibility complex. In Benacerraf, B. (ed.) Immunogenetics and Immunodeficiency, p. 81. (Baltimore: University Park Press).

    Google Scholar 

  50. Bach, F. H. and Van Rood, J. J. (1976). The major histocompatibility complex - genetics and biology. N. Engl. J. Med., 295, 806–13.

    Article  PubMed  CAS  Google Scholar 

  51. Irvine, W. J., Gray, R. J., Moriss, P. J. and Ting, A. (1977). Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs. Lancet, 2, 898–900.

    Article  PubMed  CAS  Google Scholar 

  52. Bech, K., Lunholtz, B., Nerup, J., Tomsen, M., Platz, P., Ryder, L. E., Svejgaard, A., Siersbock-Nielsen, K., Hanse, J. M., and Larsen, J. H. (1977). HLA antigens in Graves1 disease. Acta Endocrinol., 86, 510–5.

    PubMed  CAS  Google Scholar 

  53. McGregor, A. M., Smith, B. R. and Hall, R. (1980). Prediction of relapse in hyperthyroid Graves’disease. Lancet, 1, 1101–3.

    Article  PubMed  CAS  Google Scholar 

  54. Schleusener, H., Schernthaner, G., Mayr, W. R., Kotulla, P., Bogner, U., Finke, R., Meinhold, H., Koppenhagen, K. and Wenzel, K. W. (1983). HLA-DR3 and HLA-DR5 associated thyrotoxicosis - two different types of toxic diffuse goiter. J. Clin. Endocrinol. Metab., 56, 781–5.

    Article  PubMed  CAS  Google Scholar 

  55. Allannic, H., Fauchet, R., Lorcy, Y., Gueguen, M., Guerrier, A. L. and Genetel, B. (1983). A prospective study of the relationship between relapse of hyperthyroid Graves’ disease after antithyroid drugs and HLA haplotype. J. Clin. Endocrinol. Metab., 57, 719–22.

    Article  PubMed  CAS  Google Scholar 

  56. Wenzel, K. W. and Lente, J. R. (1984). Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulin in Graves’ disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab., 58, 62–9.

    Article  PubMed  CAS  Google Scholar 

  57. Weetman, A. P., Gunn, C., Hall, R. and McGregor, A. (1984). Immunosuppression by perchlorate. Lancet, 1, 906.

    Article  CAS  Google Scholar 

  58. Grumet, F. C., Payne, R. O., Konishi, J. and Kriss, J. P. (1974). HL-A antigens as markers for disease susceptibility and autoimmunity in Graves’disease. J. Clin. Endocrinol. Metab., 39, 1115–9.

    Article  PubMed  CAS  Google Scholar 

  59. Grumet, F. C., Payne, R. O., Konishi, J., Mori, T. and Kriss, J. P. (1975). HL-A antigens in Japanese patients with Graves’ disease. Tissue Antigen6, 347–52.

    Article  CAS  Google Scholar 

  60. Farid, N. R., Barnard, J. M. and Marshall, W. H. (1976). The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves’disease. Tissue Antigen., 8, 181–9.

    CAS  Google Scholar 

  61. Beck, K., Lumholtz, B., Nerup, J., Thomsen, M., Platz, P., Ryder, L. P., Svejgaard, A., Siersbck-Nielsen, K., Hansen, J. M. and Larsen, J. H. (1977). HLA antigens in Graves’ disease. Acta Endocrinol., 86, 510–6.

    Google Scholar 

  62. Farid, N. R., Sampson, E. P., Barnard, J. M., Mandeville, R., Lasen, B. and Marshall, W. H. (1979). A study of human leucocyte D locus related antigen in Graves’ disease. J. Clin. Invest., 63, 108–13.

    Article  PubMed  CAS  Google Scholar 

  63. Uno, H., Sasazuki, T., Tamai, H. and Matsumoto, H. (1981). Two major genes linked to HLA and Gm control susceptibility to Graves’ disease. Nature (London), 292, 768–70.

    Article  CAS  Google Scholar 

  64. Farid, N. R., Stone, E. and Johnson, G. (1980). Graves’ disease and HLA: clinical and epidemiological associations. Clin. Endocrinol., 13, 535–44.

    Article  CAS  Google Scholar 

  65. Schernthaner, G., Schleusner, H., Kotulla, P., Finke, R., Wenzel, B. and Mayr, W. R. (1981). Prediction of relapse or long term remission in hyperthyroid Graves’ disease. Lancet, 2, 323–5.

    Google Scholar 

  66. Sasazuki, T., Kohno, Y., Iwamoto, L. and Tanimura, M. (1977). HLA-B, D, haplotypes associated with autoimmune disease in Japanese populations. Tissue Antigens., 10, 218–24.

    Google Scholar 

  67. Wells, J. V., Fundenberg, H. H. and Mackay, I. R. (1971). Relation of the human antibody response to flagellin to Gm genotypes. J. Immunol., 107, 1505–11.

    Google Scholar 

  68. Shreffler, D. C. and Davis, D. C. (1975). The H-2 major histocompatibility complex and immune response region: genetic variations, function, and organization. Adv. Immunol., 20, 125–9.

    Article  PubMed  CAS  Google Scholar 

  69. Pandy, J. P., Fudenberg, H. H., Virella, G., Kyong, C. U., Loadholt, C. B. and Galbraith, R. M. (1979). Association between immunoglobulin allotypes and immune response to Haemophilus influenzae and Meningococcus polysaccharides. Lancet, 1, 190–2.

    Article  Google Scholar 

  70. Lieberman, K., Potter, M., Humphrey, W., Jr. and Chen, C. C. (1976). Idiotypes of insulin-binding antibodies and myeloma proteins controlled by genes linked to the allotype locus of the mouse. J. Immunol., 117, 2105–11.

    PubMed  CAS  Google Scholar 

  71. Pisetski, D. S., Piodran, S. E. and Sachs, D. H. (1978). Genetic control of the immune response to staphylococcal nuclease. J. Immunol., 122, 842–6.

    Google Scholar 

  72. Nakao, Y., Matsumoto, H., Miyazaki, T., Nishitani, H., Takasuki, K., Katsukawa, R., Nakayama, S., Izumi, S., Fujita, T. and Tsuji, K. (1980). IgG heavy chain allotypes (Gm) in autoimmune disease. Clin. Exp. Immunol., 42, 20–6.

    PubMed  CAS  Google Scholar 

  73. Farid, N. R., Newton, R. M., Noel, E. P. and Marshall, W. H. (1977). Gm phenotype in autoimmune thyroid disease. J. Immunogenet., 4,429–32.

    Article  PubMed  CAS  Google Scholar 

  74. Nakao, Y., Kishihara, M., Baba, Y., Kuma, K., Fukunishi, T. and Imura, H. (1978). HLA antigens in autoimmune thyroid disease. Arch. Intern. Med., 138, 567–70.

    Article  Google Scholar 

  75. Smith, M., Krinsky, A., Arredondo-Vega, F., Wang A. L. and Hirschhorn, K. (1981). Confirmation of the assignment of genes for human immunoglobulin heavy chains to chromosome 14 by analyses of Ig synthesis by man-mouse hybridoma. Eur. J. Immunol., 11, 852–5.

    Article  PubMed  CAS  Google Scholar 

  76. Tamai, H., Uno, H., Hirota, Y., Matsubayashi, S., Kuma, K., Matsumoto, H., Kumagi, L. F., Sasazuki, T. and Nagataki, S. (1985). Immunogenetics of Hashimoto’s and Graves’ disease. J. Clin. Endocrinol. Met ab., 60, 62–5.

    Article  CAS  Google Scholar 

  77. Farid, N. R., Barnard, J. M., Marshall, W. H., Woolferey, I. and O’Driscoll, R. F. (1977). Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. J. Clin. Endocrinol. Me tab., 45, 1165–72.

    Article  CAS  Google Scholar 

  78. Adams, D. D., Adams, Y. J., Knight, J. G., McCall, J., White, P., Parkinson, P., Horrocks, R. and Van Loghen, E. (1983). On nature of the genes influencing the prevalence of Graves’ disease. Life Sei., 31, 3–11.

    Article  Google Scholar 

  79. Sasazuki, T., Kohno, Y., Iwamoto, I., Tanimura, M. and Naito, S. (1978). Association between an HLA haplotype and low responsiveness to tetanus toxoid in man. Nature (London), 111, 359–61.

    Article  Google Scholar 

  80. Sasazuki, T., Kaneko, H., Nishimura, Y., Kaneko, R., Hayama, M. and Ohkuni, H. (1980). An HLA-linked immune suppression gene in man. J. Exp. Med., 152, 297–313.

    Google Scholar 

  81. Schwartz, M., Lifshitz, R., Givol, D., Mozes, E. and Haimovich, T. (1978). Cross-reactive idiotypic determinants on murine anti(T.G)-A-L antibodies. J. Immunol., 121,421–426.

    PubMed  CAS  Google Scholar 

  82. Greenberg, L. J., Gray, D. and Yunis, J. E. (1975). Association of HL-A5 and immune responsiveness in vitro to streptococcal antigens. J. Exp. Med., 141, 935–43.

    Article  PubMed  CAS  Google Scholar 

  83. Martin, L. and Fisher, R. A. (1951). The hereditary and familial aspects of toxic nodular goiter (secondary thyrotoxicosis). Q. J. Med., 20, 293–8.

    PubMed  CAS  Google Scholar 

  84. Fräser, G. R. (1963). A genetical study of goiter Ann. Hum. Genet., 26, 335–40.

    Article  Google Scholar 

  85. Saxena, K. M. (1965). Inheritance of thyroglobulin antibody in thyrotoxic children. Lancet, 1, 583–6.

    Article  PubMed  CAS  Google Scholar 

  86. Doniach, D. (1975). Humoral and genetic aspects of thyroid autoimmunity. Clin. Endocrinol. Metab., 4, 267–85.

    Article  CAS  Google Scholar 

  87. Farid, N. R., Von Westarp, C., Row, V. V. and Volpe, R. (1974). Studies of cell-mediated immunity (CMI) in relatives of patients with Graves’disease. J. Clin. Endocrinol. Metab., 39, 778–84.

    Article  Google Scholar 

  88. Boas, N. F. and Ober, W. B. (1945). Hereditary exophthalmic goiter - report of eleven cases in one family. J. Clin. Endocrinol. Metab., 6, 575–88.

    Article  Google Scholar 

  89. Sorensen, E. W. (1958). Thyroid diseases in a family. Acta Medica Scandinavia, 162,123–7.

    Article  CAS  Google Scholar 

  90. Wilroy, R. S. and Etteldorf, J. N. (1971). Familial hyperthyroidism including two siblings with neonatal Graves’disease. J. Pediatr., 78, 625–32.

    Article  PubMed  Google Scholar 

  91. Hollingsworth, D. R., McKean, M. E. and Roeckel, I. (1974). Goiter, immunological observations, and thyroid function tests in Down’s syndrome. Am. J. Dis. Child., Ill, 524–7.

    Google Scholar 

  92. Mason, A. M. S., Raper, C. G. and Lloyd, P. (1970). Thyrotoxicosis in a father and two sons. Lancet, 1, 81.

    Article  PubMed  CAS  Google Scholar 

  93. Hollingsworth, D. R., Mabry, C. C. and Eckerd, J. M. (1972). Hereditary aspects of Graves’ disease in infancy and childhood. J. Pediatr., 81,446–59.

    Article  PubMed  CAS  Google Scholar 

  94. Sasazuki, T., Uno, H., Yasuda, H., Tamai, H. and Matsumoto, H. (1982). Evidence for HLA-linked and Gm-linked genes in Graves’disease. In Tamir, B. B. (ed.) Human Genetics, Part B, p. 65. (New York: Liss).

    Google Scholar 

  95. Sasazuki, T., Nishimura, Y., Muto, M. and Ohta, N. (1983). HLA-linked genes controlling immune response and disease susceptibility. Immunol. Rev., 70, 51–75.

    Article  PubMed  CAS  Google Scholar 

  96. Cudworth, A. G. and Woodrow, J. C. (1975). Evidence for HLA-linked genes in ’juvenile’ diabetes mellitus. Br. Med. J., 3, 133–5.

    Article  PubMed  CAS  Google Scholar 

  97. Day, N. E. and Simons, M. J. (1976). Disease susceptibility genes. Their identification by multiple case family studies. Tissue Antigen., 8, 109–19.

    CAS  Google Scholar 

  98. Thomson, G. and Bodmer, W. F. (1977). The genetics of HLA and disease association. In Christianess, T. B. and Feachel, T. M. (eds.) Measuring Selection in National Populations. p. 545. (Berlin: Springer-Verlag).

    Google Scholar 

  99. Svejgaard, A. and Ryder, L. P. (1981). HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann. Hum. Genet., 45, 293–8.

    Article  PubMed  CAS  Google Scholar 

  100. Farid, N. P. and Bear, J. C. (1983). Autoimmune endocrine disorders and the major histocompatibility complex. In Davis, T. (ed.) Autoimmune Endocrine Disease, p. 59. (New York: Wiley and Sons).

    Google Scholar 

  101. Stenszky, V., Kozma, L., Balazs, Cs., Rocheitz, Sz., Bear, J. C. and Farid, N. R. (1985). The genetics of Graves’ disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab., 61, 735–40.

    Article  PubMed  CAS  Google Scholar 

  102. Farid, N. R. (1981). Graves’disease. In Farid, N. R. (ed.) HLA in Endocrine and Metabolic Disorders, p. 85. (New York: Academic Press).

    Google Scholar 

  103. Chan, S. H., Yeo, P. P. B., Cheah, J. S. and Lim, P. (1980). HLA haplotype sharing in affected siblings in multiple case Chinese families with thyrotoxicosis. Tissue Antigen16, 258–63.

    Article  CAS  Google Scholar 

  104. Joassoo, A., Robertson, P. and Murray, I. P. C. (1975). Viral antibodies in thyrotoxicosis. Lancet, 2, 125.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 MTP Press Limited

About this chapter

Cite this chapter

Tamai, H., Kumagai, L.F., Nagataki, S. (1986). Immunogenetics of Graves’ Disease. In: McGregor, A.M. (eds) Immunology of Endocrine Diseases. Immunology and Medicine, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4171-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4171-7_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8352-2

  • Online ISBN: 978-94-009-4171-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics